Big Gain For Dermata Therapeutics Inc.

Fri, Aug 02, 2024 at 07:08 PM

Dermata Therapeutics Inc. (DRMA:NASDAQ) jumped higher at $3.22, representing a gain of 29.8%. On Fri, Aug 02, 2024, DRMA:NASDAQ touched a New 2-Week High of $3.22. The stock appeared on our News Catalysts scanner on Wed, Jul 17, 2024 at 10:05 AM in the 'BIOTECH' category. From Fri, Jul 19, 2024, the stock recorded 30.00% Up Days and 36.36% Green Days

The stock spiked on Wed, Jul 24, 2024 at $5 with a volume of 65M+.

About Dermata Therapeutics Inc. (DRMA:NASDAQ)

Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.

Top 10 Gainers:

VSee Health Inc Com (VSEE:NASDAQ), 74.9%
OS Therapies Incorporated (OSTX:NYSEMKT), 59.36%
MKDWELL Tech Inc. (MKDW:NASDAQ), 54.81%
Shimmick Corporation (SHIM:NASDAQ), 49.24%
Translate Bio, Inc. (TBIO:NASDAQ), 30.33%
Dermata Therapeutics Inc. (DRMA:NASDAQ), 29.84%
TOYO Co. Ltd (TOYO:NASDAQ), 27.15%
Republic First Bancorp, Inc. (FRBK:NASDAQ), 24%
MOGU Inc. (MOGU:NYSE), 23.95%
Cassava Sciences, Inc. (SAVA:NASDAQ), 23.93%